KLRC1 and Parkinson disease: Our data showed no significant differences in frequencies of NKG2A in the CD56dim NK subset (Fig. 4H) or the CD56− NK subset (Fig. 4I) among groups of HC, PD patients with early stages (<4 years), or those with later stages (4+ years).